MAYNE PHARMA GROUP LIMITED — M&A Activity 2012

Nov 14, 2012

==> picture [115 x 58] intentionally omitted <==

15 November 2012

METRICS, INC. ACQUISITION COMPLETED

The Board of Mayne Pharma Group Limited (Mayne Pharma; ASX: MYX) is pleased to announce the completion of the acquisition of Metrics, Inc. (Metrics). The acquisition, announced on 4 October 2012, was funded by conditional and unconditional placements, an underwritten 1-for-1 non-renounceable entitlement offer and a US$44.5m acquisition debt facility. Both the retail and institutional components of the equity raising received strong support from shareholders and were oversubscribed.

Mayne Pharma CEO Mr Scott Richards said, “We are pleased to have now completed the acquisition of Metrics. The acquisition is extremely exciting and positive for Mayne Pharma and will transform the existing business by diversifying its product range, technologies and international footprint. The two businesses are highly complementary and significant upside is expected in the medium to long term from cross-selling opportunities.”

-ENDS-

For further information contact:

Scott Richards +61 8 8209 2410 Lisa Pendlebury +61 419 548 434, lisa.pendlebury@maynepharma.com